Product NDC: | 0904-6266 |
Proprietary Name: | Allopurinol |
Non Proprietary Name: | Allopurinol |
Active Ingredient(s): | 100 mg/1 & nbsp; Allopurinol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0904-6266 |
Labeler Name: | Major Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071586 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111201 |
Package NDC: | 0904-6266-61 |
Package Description: | 100 TABLET, COATED in 1 BOX, UNIT-DOSE (0904-6266-61) |
NDC Code | 0904-6266-61 |
Proprietary Name | Allopurinol |
Package Description | 100 TABLET, COATED in 1 BOX, UNIT-DOSE (0904-6266-61) |
Product NDC | 0904-6266 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Allopurinol |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20111201 |
Marketing Category Name | ANDA |
Labeler Name | Major Pharmaceuticals |
Substance Name | ALLOPURINOL |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] |